Abstract
Acute Respiratory Distress Syndrome (ARDS) is characterized by respiratory dysfunction including hypoxemia and decreased lung compliance. The definition for ARDS according to the American-European Consensus Conference on ARDS [1] stipulates: 1. acute onset; 2. PaO2 < 200 mmHg; 3. bilateral infiltrates as seen on a frontal chest radiograph; and 4. pulmonary artery wedge pressure < 18 mmHg or no clinical evidence of left atrial hypertension.
Keywords
- Acute Respiratory Distress Syndrome
- Adult Respiratory Distress Syndrome
- Pulmonary Artery Wedge Pressure
- Aerosol Delivery
- Surfactant Therapy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bernard GR, Artigas A, Brigham KL et al (1994) Report of the American-European Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J Crit Care 9: 72-81
Luhr OR, Antonsen K, Karlsson M et al (1999) Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. Am J Respir Crit Care Med 159: 1849-1861
Seeger W, Stohr G, Wolf HR et al (1985) Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58: 326 - 338
Lachmann B, Robertson B, Vogel J (1980) In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand 24: 231 - 236
Lachmann B, Jonson B, Lindroth M (1982) Modes of artificial ventilation in severe respiratory distress syndrome. Lung function and morphology in rabbits after wash-out of alveolar surfactant. Crit Care Med 10: 724-732
Lachmann B, Van Daal G-J (1992) Adult Respiratory Distress Syndrome: Animal Models. In: Robertson B, Van Golde LMG, Batenburg JJ (eds) Pulmonary Surfactant: from molecular biology to clinical practice. Elsevier Science Publishers BV, pp 635 - 663
Eijking EP, Gommers D, So KL et al (1993) Prevention of respiratory failure after hydrochloric acid aspiration by intratracheal surfactant instillation in rats [see comments]. Anesth Analg 76: 472 - 477
Segerer H, van Gelder W, Angenent FW (1993) Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique. Pediatr Res 34: 490 - 494
Gilliard N, Richman PM, Merritt TA (1990) Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury. Am Rev Respir Dis 141: 743 - 747
Lewis JF, Tabor B, Ikegami M et al (1993) Lung function and surfactant distribution in saline-lavaged sheep given instilled vs. nebulized surfactant. J Appl Physiol 74: 1256 - 1264
Gommers D, Eijking EP, So KL et al (1998) Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome ( ARDS ). Intensive Care Med 24: 494-500
Gommers D, van't Veen A, Verbrugge SJC et al (1998) Comparison of eight different surfactant preparations on improvement of blood gases in lung-lavaged rats. Appl Cardiopulm Pathophysiol 7: 95 - 102
Gommers D, Lachmann B (1993) Surfactant therapy: does it have a role in adults? Clin Intensive Care 4: 284 - 295
Walmrath D, Gunther A, Ghofrani HA et al (1996) Bronchoscopie surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 154: 57 - 62
Gregory TJ, Steinberg KP, Spragg R et al (1997) Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155: 1309 - 1315
Anzueto A, Baughman RP, Guntupalli KK et al (1996) Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. N Engl J Med 334: 1417 - 1421
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Italia
About this paper
Cite this paper
Haitsma, J.J., Lachmann, B. (2000). Rationale for Exogenous Surfactant in Acute Respiratory Distress Syndrome. In: Gullo, A. (eds) Anesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/978-88-470-2286-7_7
Download citation
DOI: https://doi.org/10.1007/978-88-470-2286-7_7
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0095-7
Online ISBN: 978-88-470-2286-7
eBook Packages: Springer Book Archive